Palo Alto, CA, United States of America

Pamela B Conley

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Pamela B. Conley

Introduction

Pamela B. Conley is a prominent inventor based in Palo Alto, California, known for her significant contributions to the field of pharmaceuticals. With a total of 17 patents to her name, she has made remarkable advancements, particularly in the development of antidotes for anticoagulants.

Latest Patents

Among her latest patents is a groundbreaking work on antidotes to factor Xa inhibitors. This patent focuses on factor Xa protein derivatives that effectively bind to factor Xa inhibitors, thereby neutralizing their effects without forming the prothrombinase complex. Another notable patent involves the preparation of factor Xa derivatives, detailing methods for large-scale manufacturing that yield highly pure protein products. This method includes the use of detergents and various chromatographic techniques to ensure high-quality results.

Career Highlights

Throughout her career, Pamela has worked with esteemed companies such as Portola Pharmaceuticals, Inc. and Alexion Pharmaceuticals, Inc. Her expertise in the pharmaceutical industry has allowed her to contribute to innovative solutions that address critical health challenges.

Collaborations

Pamela has collaborated with talented individuals in her field, including Genmin Lu and Uma Sinha. These partnerships have fostered a collaborative environment that enhances the development of new technologies and solutions.

Conclusion

Pamela B. Conley's work exemplifies the impact of innovation in the pharmaceutical industry. Her patents and collaborations highlight her dedication to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…